An insight into the TAM system in Alzheimer?s disease

被引:8
|
作者
Zhou, Shiqi [1 ]
Li, Yanyan [1 ]
Zhang, Zhao [1 ]
Yuan, Yuhe [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China
[2] Chinese850 Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Dept Pharmacol, I Xiannongtan St, Beijing 100050, Peoples R China
基金
北京市自然科学基金;
关键词
TAM system; Neuroinflammation; Microglia; A; Biomarker; Alzheimer?s disease; RECEPTOR TYROSINE KINASES; PROTEIN-S; VITAMIN-K; APOPTOTIC CELLS; IMMUNE-SYSTEM; SOLUBLE FORM; GAS6; BRAIN; AXL; MICROGLIA;
D O I
10.1016/j.intimp.2023.109791
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The TAM receptors may help delay the progression of Alzheimer's disease (AD). AD is the most common neurodegenerative disease associated with human aging. The TAM receptors, derived from the first letter of its three constituents -Tyro3, Axl, and Mertk, are associated with immune responses, cellular differentiation and migration, and clearance of apoptotic cells and debris, with the two canonical ligands, Growth Arrest Specific 6 (Gas6) and ProS1. Several kinds of research have indicated the participation of the TAM system in AD pathology. Also, the TAMs regulate multiple features of microglia, the significant sensors of disorder in the central nervous system (CNS).In this review, we describe the biology of the TAM receptors and ligands in the CNS. Then, we discuss the relationship between the TAM system and AD, specially focusing on its functional expression in the microglia. Finally, we also summarize some agents that could interfere with the TAM signaling pathways and discuss potential difficulties and strategies for drug development.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Complement System in Alzheimer's Disease
    Shah, Akash
    Kishore, Uday
    Shastri, Abhishek
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [42] Opioid System and Alzheimer's Disease
    Cai, Zhiyou
    Ratka, Anna
    NEUROMOLECULAR MEDICINE, 2012, 14 (02) : 91 - 111
  • [43] Nicotinic system and Alzheimer's disease
    Gambassi, G
    Landi, F
    Bernabei, R
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (05) : 655 - 656
  • [44] Dysregulation of TLR5 and TAM Ligands in the Alzheimer’s Brain as Contributors to Disease Progression
    Marisol Herrera-Rivero
    Francesco Santarelli
    Frederic Brosseron
    Markus P. Kummer
    Michael T. Heneka
    Molecular Neurobiology, 2019, 56 : 6539 - 6550
  • [45] Dysregulation of TLR5 and TAM Ligands in the Alzheimer's Brain as Contributors to Disease Progression
    Herrera-Rivero, Marisol
    Santarelli, Francesco
    Brosseron, Frederic
    Kummer, Markus P.
    Heneka, Michael T.
    MOLECULAR NEUROBIOLOGY, 2019, 56 (09) : 6539 - 6550
  • [46] Dietary Polyphenols as Therapeutic Intervention for Alzheimer's Disease: A Mechanistic Insight
    Bukhari, Syed Nasir Abbas
    ANTIOXIDANTS, 2022, 11 (03)
  • [47] Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues
    Kumari, Sneha
    Dhapola, Rishika
    Reddy, Dibbanti HariKrishna
    APOPTOSIS, 2023, 28 (7-8) : 943 - 957
  • [48] An insight into Alzheimer’s disease and its on-setting novel genes
    Jaanaky Vigneswaran
    Sivaloganathan Anogh Muthukumar
    Mohamed Shafras
    Geetika Pant
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57
  • [49] Why Alzheimer's Disease Starts with a Memory Impairment: Neurophysiological Insight
    Arshavsky, Yuri I.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (01) : 5 - 16
  • [50] Apathy and loss of insight in Alzheimer's disease: A SPECT imaging study
    Ott, BR
    Noto, RB
    Fogel, BS
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1996, 8 (01) : 41 - 46